Ad is loading...
MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.
CLSD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Clearside Biomedical (CLSD) Earnings Date & Reports

A.I. Advisor
published Earnings

CLSD is expected to report earnings to rise 10.00% to -10 cents per share on March 18

Clearside Biomedical CLSD Stock Earnings Reports
Q4'24
Est.
$-0.11
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.03
Q1'24
Missed
by $0.03
Q4'23
Beat
by $0.01
The last earnings report on November 12 showed earnings per share of -10 cents, beating the estimate of -11 cents. With 435.64K shares outstanding, the current market capitalization sits at 74.00M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CLSD
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For CLSD
(Try 14 days for Free)
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of drug therapies to treat chronic, blinding diseases of the eye

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
900 North Point Parkway
Phone
+1 678 270-3631
Employees
30
Web
https://www.clearsidebio.com